tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Degeeter, 107 are a BUY (92.24%), 8 are a HOLD (6.9%), 1 are a SELL (0.86%).
Analyst Kevin Degeeter, currently employed at LADENBURG, carries an average stock price target met ratio of 48.59% that have a potential upside of 49.73% achieved within 299 days. Previously, Kevin Degeeter worked at OPPENHEIMER.
Kevin Degeeter’s has documented 213 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVCR, Novocure Ltd at 07-Jul-2025.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 1/12/2021. The price target of $51 was fulfilled within 1 day with a profit of $3.41 (7.17%) receiving and performance score of 71.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$11
$9.07 (469.95%)
$10
2 months 13 days ago
(17-Aug-2025)
0/2 (0%)
$7.85 (249.21%)
Buy
$8
$6.07 (314.51%)
5 months 11 days ago
(19-May-2025)
1/2 (50%)
$4.23 (112.20%)
25
Hold
$4
$2.07 (107.25%)
$60
6 months 29 days ago
(01-Apr-2025)
2/5 (40%)
$0.25 (6.67%)
8
Hold
$120
1 years 1 months 21 days ago
(09-Sep-2024)
1/3 (33.33%)
$53.4 (80.18%)
69
Buy
$80
2 years 9 months 25 days ago
(05-Jan-2023)
2/3 (66.67%)
$58.3 (268.66%)
204
Which stock is Kevin Degeeter is most bullish on?
Which stock is Kevin Degeeter is most reserved on?
What Year was the first public recommendation made by Kevin Degeeter?
